The Dark Price of Medical Collaboration with China
|
Time
Text
Just a few days before this hot mic moment, uh Armstrong Williams in the Baltimore Sun, he's part owner there, uh, published one of his staff commentaries.
He does it every week, and he published this very powerful op-ed um about uh the cost of engagement with communist China, because if you recall, Secretary Kennedy uh about a month ago uh basically announced that there were American hospitals that were violating the dead donor rule, um, meaning that um you know, basically people who weren't sufficiently dead.
I mean, this let me qualify this just very briefly.
It's an ethical question how you decide if someone is really dead when you harvest their organs, because you can't harvest from a completely dead body.
They need to be brain dead and body alive.
That's there's a standard there, and that we have teams of people who are involved in transplant ethics who figure out is this a reasonable person to transplant from or not, right?
Is the accident sufficient?
Are they really brain dead?
And mistakes are made in this.
This is a this is a uh a fraught area, right?
That that has to be figured out.
We what we want to be doing is erring on the conservative side.
And if if someone has a chance of living to giving them that chance, right?
Um, and unfortunately in our uh transplant industry, things have been kind of shifting in a bit in the other direction.
There was even an op-ed some weeks ago in the New York Times, I suppose not surprisingly, arguing for the redefinition of the dead donor rule, basically making it the death a little less someone classifying someone as dead who's actually a little less dead, right?
Kind of easing so that uh easing the rules so that there could be more donor uh organs available for donation.
Well, so what Armstrong argues, I think very poignantly in this piece is that that this is the cost of engagement with communist China.
And I was actually just, I've been just reading reports as I'm researching for for this book, uh Kill to Order, uh that I'm writing, there's actually an unbelievable level of engagement between uh, you know, basically medical companies, um uh hospitals, research, and so forth with communist China.
The thing I've been reading recently, um uh a lot of the materials that are used for organ transplantation in China actually come from the West.
That's one of the routes of this engagement that I wasn't even you know fully, fully aware of.
But you know, basically, in in uh the American Journal of Transplantation just a few years ago, there's a paper titled Execution by Organ Procurement.
And we're talking about communist China here.
And so what they found was they did this non-exhaustive search through a few thousand papers, uh uh Chinese uh transplant research related papers, and they found at least 70 instances where that dead donor rule was violated, meaning that you know what the researchers, the Chinese researchers written into their actual methods is that uh they killed the person by the organ extraction itself.
Okay, that and the way I read that uh uh at the time and and still do is that it's just so normalized there.
It's just the kind of the standard way that that organ transplantation is done.
They don't even realize that they're doing something wrong per, you know, the kind of this redefinition of what's ethical or not.
I think that uh I wholly agree with Armstrong on this, uh, that basically through this engagement, you know, deep engagement around the transplant industry, medical industry at large, training transplant doctors, all of that, again, we had this mentality we're gonna change China, we're gonna help China, we're gonna help them, you know, develop.